Table 4.
Cost-effectiveness of Clostridioides difficile Infection Treatment Strategies
Strategy No. | Nonsevere | Severe | First Recurrence | Second or Later Recurrence | Cost | Incremental Cost | Effectiveness, QALYs | Incremental Effectiveness, QALYs | ICER, $/QALY |
---|---|---|---|---|---|---|---|---|---|
3 | Metronidazole | Vancomycin | Vancomycin | Vancomycin | $64 509 | … | 12.280 | … | … |
1 | Vancomycin | Vancomycin | Vancomycin | Vancomycin | $64 692 | $183 | 12.352 | 0.072 | 2537 |
25 | Vancomycin | Vancomycin | Vancomycin | Vancomycin + rifaximin | $64 917 | $225 | 12.406 | 0.054 | 4208 |
37 | Vancomycin | Vancomycin | Vancomycin | FMT | $65 125 | $208 | 12.426 | 0.020 | 10 383 |
43 | Vancomycin | Vancomycin | Fidaxomicin | FMT | $65 411 | $286 | 12.442 | 0.016 | 27 428 |
44 | Fidaxomicin | Vancomycin | Fidaxomicin | FMT | $65 889 | $478 | 12.451 | 0.009 | 31 751 |
All costs are given as US dollars.
Abbreviations: FMT, fecal microbiota transplantation; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.